Literature DB >> 2901814

Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles.

S R Max1, J Mill, K Mearow, M Konagaya, Y Konagaya, J W Thomas, C Banner, L Vitković.   

Abstract

The regulation of glutamine synthetase expression by dexamethasone was studied in rat skeletal muscles. Daily administration of dexamethasone caused striking enhancement of glutamine synthetase activity in plantaris, soleus, and diaphragm muscles. Northern blot analysis revealed that the dexamethasone-mediated increase of glutamine synthetase activity was associated with dramatically increased levels of glutamine synthetase mRNA. Both glutamine synthetase activity and mRNA levels were significantly elevated in plantaris muscle at 0.5 mg.kg-1.day-1 of dexamethasone, a dose that approximates endogenous corticosteroid levels in animals under severe stress. Quantification of changes in glutamine synthetase mRNA on the basis of total mRNA (by oligo dT hybridization) also revealed a major increase in glutamine synthetase mRNA. Dexamethasone was without effect on beta-tubulin mRNA levels, indicating that glutamine synthetase induction is not part of a global response to glucocorticoids. Dexamethasone treatment resulted in only an approximately 15% increase in glutamine synthetase activity in heart; there was no change in glutamine synthetase mRNA level in this tissue. Thus glucocorticoids regulate glutamine synthetase gene expression in rat skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901814     DOI: 10.1152/ajpendo.1988.255.3.E397

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Glutamine, insulin and glucocorticoids regulate glutamine synthetase expression in C2C12 myotubes, Hep G2 hepatoma cells and 3T3 L1 adipocytes.

Authors:  Yanxin Wang; Malcolm Watford
Journal:  Biochim Biophys Acta       Date:  2006-11-23

2.  Estrogen (17beta-estradiol) enhances glutamine synthetase activity in C6-glioma cells.

Authors:  N Haghighat
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

3.  Effect of dibutyryl cyclic AMP and dexamethasone on glutamine synthetase gene expression in rat astrocytes in culture.

Authors:  M J Jackson; H R Zielke; S R Max
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

4.  Physiological glucocorticoid levels regulate glutamine and insulin-mediated glucose metabolism in skeletal muscle of the rat. Studies with RU 486 (mifepristone).

Authors:  B Leighton; M Parry-Billings; G Dimitriadis; J Bond; E A Newsholme; C DaCosta; E A Foot
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 5.  The Medical Management of Cerebral Edema: Past, Present, and Future Therapies.

Authors:  Michael R Halstead; Romergryko G Geocadin
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  Modeling circadian rhythms of glucocorticoid receptor and glutamine synthetase expression in rat skeletal muscle.

Authors:  Zhenling Yao; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2006-02-02       Impact factor: 4.200

7.  Mitochondrial energy metabolism in a model of undernutrition induced by dexamethasone.

Authors:  Jean-François Dumas; Gilles Simard; Damien Roussel; Olivier Douay; Françoise Foussard; Yves Malthiery; Patrick Ritz
Journal:  Br J Nutr       Date:  2003-11       Impact factor: 3.718

8.  Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney.

Authors:  M K Chen; N J Espat; K I Bland; E M Copeland; W W Souba
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

9.  Effect of 8-bromo-cAMP and dexamethasone on glutamate metabolism in rat astrocytes.

Authors:  H R Zielke; J T Tildon; M E Landry; S R Max
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

10.  Induction of glutamine synthetase by 8-bromo cyclic AMP in primary cultures of rat brain astrocytes.

Authors:  S R Max; M E Landry; H R Zielke
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.